Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Zongertinib for Solid Tumors
Recruiting1 awardPhase 2
Anchorage, Alaska
"This trial is for adults with advanced cancer who have not responded to previous treatments or for whom no treatment is available. The study is investigating whether a medication called zongertinib can help people with
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service